FR8018M - - Google Patents

Info

Publication number
FR8018M
FR8018M FR128733A FR128733A FR8018M FR 8018 M FR8018 M FR 8018M FR 128733 A FR128733 A FR 128733A FR 128733 A FR128733 A FR 128733A FR 8018 M FR8018 M FR 8018M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR128733A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Application granted granted Critical
Publication of FR8018M publication Critical patent/FR8018M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR128733A 1966-11-18 1967-11-17 Expired FR8018M (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (1)

Publication Number Publication Date
FR8018M true FR8018M (fi) 1970-08-03

Family

ID=27516268

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1584222D Expired FR1584222A (fi) 1966-11-18 1967-11-17
FR128733A Expired FR8018M (fi) 1966-11-18 1967-11-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1584222D Expired FR1584222A (fi) 1966-11-18 1967-11-17

Country Status (12)

Country Link
JP (1) JPS4938267B1 (fi)
BE (1) BE706625A (fi)
CH (9) CH554884A (fi)
DE (2) DE1670005C2 (fi)
ES (1) ES347319A1 (fi)
FI (1) FI50416C (fi)
FR (2) FR1584222A (fi)
IL (1) IL28803A (fi)
LU (1) LU54891A1 (fi)
NL (1) NL157012B (fi)
PL (1) PL72562B1 (fi)
SE (2) SE369307B (fi)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0513387A1 (en) * 1990-11-30 1992-11-19 Otsuka Pharmaceutical Co., Ltd. Active oxygen inhibitor
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (fi) * 1974-07-18 1976-01-30
JPS5182675A (fi) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (fi) * 1965-10-07

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0513387A1 (en) * 1990-11-30 1992-11-19 Otsuka Pharmaceutical Co., Ltd. Active oxygen inhibitor
EP0513387A4 (en) * 1990-11-30 1993-04-21 Otsuka Pharmaceutical Co., Ltd. Active oxygen inhibitor
US5643932A (en) * 1990-11-30 1997-07-01 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US5677319A (en) * 1990-11-30 1997-10-14 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
EP0934937A1 (en) * 1990-11-30 1999-08-11 Otsuka Pharmaceutical Co., Ltd. Azole derivatives as superoxide radical inhibitor
US6080764A (en) * 1990-11-30 2000-06-27 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
EP1130017A2 (en) * 1990-11-30 2001-09-05 Otsuka Pharmaceutical Co., Ltd. Azole derivatives and their use as superoxide radical inhibitors
EP1130017A3 (en) * 1990-11-30 2001-09-19 Otsuka Pharmaceutical Co., Ltd. Azole derivatives and their use as superoxide radical inhibitors
USRE37556E1 (en) 1990-11-30 2002-02-19 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation

Also Published As

Publication number Publication date
FI50416B (fi) 1975-12-01
NL6715532A (fi) 1968-05-20
CH545310A (de) 1973-12-15
CH554884A (de) 1974-10-15
IL28803A (en) 1974-05-16
CH528531A (de) 1972-09-30
DE1670005C2 (de) 1982-06-09
LU54891A1 (fi) 1968-02-08
DE1795822C2 (de) 1982-07-15
JPS4938267B1 (fi) 1974-10-16
SE369307B (fi) 1974-08-19
FI50416C (fi) 1976-03-10
CH560203A5 (fi) 1975-03-27
BE706625A (fi) 1968-05-16
FR1584222A (fi) 1969-12-19
SE422209B (sv) 1982-02-22
ES347319A1 (es) 1969-05-16
NL157012B (nl) 1978-06-15
CH536311A (de) 1973-04-30
CH545309A (de) 1973-12-15
DE1670005A1 (de) 1970-08-06
PL72562B1 (en) 1974-08-30
CH560205A5 (fi) 1975-03-27
CH545308A (de) 1973-12-15
CH556351A (de) 1974-11-29

Similar Documents

Publication Publication Date Title
FI50416B (fi)
AU5917865A (fi)
AU424443B2 (fi)
AU428063B2 (fi)
AU421822B2 (fi)
AU417216B2 (fi)
AU415165B1 (fi)
AU414526B2 (fi)
AU433222B2 (fi)
BE689645A (fi)
BE693972A (fi)
BE694234A (fi)
AU415780B2 (fi)
BE693692A (fi)
BE694605A (fi)
BE693663A (fi)
BE674713A (fi)
BE693659A (fi)
BE693215A (fi)
BE693078A (fi)
BE692491A (fi)
BE692353A (fi)
BE691232A (fi)
BE693811A (fi)
BE688869A (fi)